VEGF has been shown to impair leukocyte‐endothelial interactions by reducing the adhesion molecules, ICAM‐1, VCAM‐1, and LFA‐1, in angiogenic vessels and hampering the infiltration of T‐effector cells into tumours.33, 34. Here, VEGFA is linked to neoplasm.